Mr. Sender will be responsible for leading Synergy’s financial strategy and operations, supporting all functions of the organization. “Gary is a strong leader whose broad experience in small and larger specialty pharmaceutical organizations uniquely qualifies him to lead and build our financial operations as we enter a transformative period in our history,” said Gary Jacob, chairman and chief executive officer, Synergy.
“Having previously managed financial planning and analysis and strategic growth initiatives of Shire’s global commercial businesses, Gary has a thorough understanding of the exciting opportunities from which Synergy is poised to benefit. I’m confident he can add significant value as we prepare to successfully enter a growing and dynamic GI market.”
Mr. Sender has over 25 years of financial leadership experience in the pharmaceutical and biopharmaceutical industries, most recently at Shire plc. From 2009-2015 he served as senior vice president, finance supporting its specialty pharmaceuticals business and subsequently its global commercial businesses.
